{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:29:40Z","timestamp":1768418980767,"version":"3.49.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82174183"],"award-info":[{"award-number":["No. 82174183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82204842"],"award-info":[{"award-number":["No. 82204842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the three-year clinical action Plan of Shanghai Shenkang Hospital Development Center","award":["No. SHDC2020CR4052"],"award-info":[{"award-number":["No. SHDC2020CR4052"]}]},{"name":"the YangFan project from the Science and Technology Commission of Shanghai Municipality","award":["No. 22YF1445400"],"award-info":[{"award-number":["No. 22YF1445400"]}]},{"name":"This study was supported by Shanghai University of Traditional Chinese Medicine Science and Technology Development Project","award":["24KFL090"],"award-info":[{"award-number":["24KFL090"]}]},{"name":"Shanghai Three-year Action Plan to Further Accelerate the Development of Traditional Chinese Medicine Inheritance and Innovation","award":["No.ZY(2021-2023)-0211"],"award-info":[{"award-number":["No.ZY(2021-2023)-0211"]}]},{"name":"Shanghai famous old Chinese medicine academic experience research studio construction project","award":["No. SHGZS-202210"],"award-info":[{"award-number":["No. SHGZS-202210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Proced Online"],"DOI":"10.1186\/s12575-025-00312-2","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T04:36:26Z","timestamp":1764909386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["(-)-Guaiol Downregulates M2 Tumor-Associated Macrophage Polarization Through PPAR-\u03b3 Signaling to Suppress Lung Cancer"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5812-2063","authenticated-orcid":false,"given":"Zhen-Yu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Bin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"3","key":"312_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"312_CR2","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jama.2018.13995","volume":"320","author":"DB Johnson","year":"2018","unstructured":"Johnson DB, Chandra S, Sosman JA. Immune checkpoint inhibitor toxicity in 2018. JAMA. 2018;320(16):1702\u20133.","journal-title":"JAMA"},{"issue":"1","key":"312_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00854-y","volume":"20","author":"A Naimi","year":"2022","unstructured":"Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, et al. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Commun Signal. 2022;20(1):44.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"312_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.emc.2025.03.003","volume":"43","author":"AS Meara","year":"2025","unstructured":"Meara AS, Zois JP, Bischof JJ. Immunotherapy complications: immune checkpoint inhibitors. Emerg Med Clin North Am. 2025;43(3):489\u2013501.","journal-title":"Emerg Med Clin North Am"},{"issue":"3","key":"312_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/exd.14716","volume":"32","author":"S Kawashima","year":"2023","unstructured":"Kawashima S, Togashi Y. Resistance to immune checkpoint inhibitors and the tumor microenvironment. Exp Dermatol. 2023;32(3):240\u20139.","journal-title":"Exp Dermatol"},{"issue":"10","key":"312_CR6","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1111\/cas.15497","volume":"113","author":"J Nagasaki","year":"2022","unstructured":"Nagasaki J, Ishino T, Togashi Y. Mechanisms of resistance to immune checkpoint inhibitors. Cancer Sci. 2022;113(10):3303\u201312.","journal-title":"Cancer Sci"},{"issue":"2","key":"312_CR7","doi-asserted-by":"publisher","first-page":"ITC17","DOI":"10.7326\/AITC202402200","volume":"177","author":"M Ramos-Casals","year":"2024","unstructured":"Ramos-Casals M, Siso-Almirall A. Immune-related adverse events of immune checkpoint inhibitors. Ann Intern Med. 2024;177(2):ITC17\u201332.","journal-title":"Ann Intern Med"},{"issue":"6","key":"312_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ. The pathogenesis of cancer metastasis: the\u2019seed and soil\u2019hypothesis revisited. Nat Rev Cancer. 2003;3(6):453\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"312_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0878-0","volume":"37","author":"F Xu","year":"2018","unstructured":"Xu F, Cui WQ, Wei Y, Cui J, Qiu J, Hu LL, et al. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling. J Exp Clin Cancer Res. 2018;37(1):207.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"312_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1027-0","volume":"38","author":"W Ren","year":"2019","unstructured":"Ren W, Hou J, Yang C, Wang H, Wu S, Wu Y, et al. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. J Exp Clin Cancer Res. 2019;38(1):62.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"312_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bbrc.2017.06.071","volume":"490","author":"X Yu","year":"2017","unstructured":"Yu X, Xu M, Li N, Li Z, Li H, Shao S, et al. \u03b2-elemene inhibits tumor-promoting effect of M2 macrophages in lung cancer. Biochem Biophys Res Commun. 2017;490(2):514\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"312_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108468","volume":"104","author":"Z Wu","year":"2022","unstructured":"Wu Z, Zhou J, Chen F, Yu J, Li H, Li Q, et al. 13-methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages. Int Immunopharmacol. 2022;104:108468.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"312_CR13","first-page":"925","volume":"13","author":"Q Wu","year":"2015","unstructured":"Wu Q, Chen GL, Li YJ, Chen Y, Lin FZ. Paeoniflorin inhibits macrophage-mediated lung cancer metastasis. Chin J Nat Med. 2015;13(12):925\u201332.","journal-title":"Chin J Nat Med"},{"issue":"9","key":"312_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19817","volume":"9","author":"Y Cao","year":"2023","unstructured":"Cao Y, Wu Y, Tu H, Gu Z, Yu F, Huang W, et al. Guaiol inhibit epithelial-mesenchymal transition in lung cancer via suppressing M2 macrophages mediated STAT3 signaling pathway. Heliyon. 2023;9(9):e19817.","journal-title":"Heliyon"},{"issue":"1","key":"312_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28.","journal-title":"Mol Cancer"},{"issue":"1","key":"312_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10555-019-09794-5","volume":"38","author":"J Lu","year":"2019","unstructured":"Lu J. The Warburg metabolism fuels tumor metastasis. Cancer Metastasis Rev. 2019;38(1):157\u201364.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"312_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4331\/wjbc.v6.i3.148","volume":"6","author":"M Lee","year":"2015","unstructured":"Lee M, Yoon JH. Metabolic interplay between glycolysis and mitochondrial oxidation: the reverse Warburg effect and its therapeutic implication. World J Biol Chem. 2015;6(3):148\u201361.","journal-title":"World J Biol Chem"},{"issue":"1","key":"312_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-022-00406-1","volume":"8","author":"J Chen","year":"2022","unstructured":"Chen J, Zou L, Lu G, Grinchuk O, Fang L, Ong DST, et al. PFKP alleviates glucose starvation-induced metabolic stress in lung cancer cells via AMPK-ACC2 dependent fatty acid oxidation. Cell Discov. 2022;8(1):52.","journal-title":"Cell Discov"},{"issue":"3","key":"312_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10555-022-10059-x","volume":"41","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee A, Bilecz AJ, Lengyel E. The adipocyte microenvironment and cancer. Cancer Metastasis Rev. 2022;41(3):575\u201387.","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"312_CR20","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.ajpath.2023.06.014","volume":"193","author":"D Zhu","year":"2023","unstructured":"Zhu D, Nie Y, Zhao Y, Chen X, Yang Z, Yang Y. RNF152 suppresses fatty acid oxidation and metastasis of lung adenocarcinoma by inhibiting IRAK1-mediated AKR1B10 expression. Am J Pathol. 2023;193(10):1603\u201317.","journal-title":"Am J Pathol"},{"issue":"1","key":"312_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1180","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu X, Liu Y, Yan F, Zeng Y, Song Y, et al. Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long-chain acyl\u2010coenzyme A synthase 5. Clin Transl Med. 2023;13(1):e1180.","journal-title":"Clin Transl Med"},{"issue":"1","key":"312_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/imm.12543","volume":"147","author":"F Xiu","year":"2016","unstructured":"Xiu F, Diao L, Qi P, Catapano M, Jeschke MG. Palmitate differentially regulates the polarization of differentiating and differentiated macrophages. Immunology. 2016;147(1):82\u201396.","journal-title":"Immunology"},{"issue":"6","key":"312_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002548","volume":"9","author":"S Liu","year":"2021","unstructured":"Liu S, Zhang H, Li Y, Zhang Y, Bian Y, Zeng Y, et al. S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation. J Immunother Cancer. 2021;9(6):e002548.","journal-title":"J Immunother Cancer"},{"issue":"15","key":"312_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512032","volume":"24","author":"E Vassiliou","year":"2023","unstructured":"Vassiliou E, Farias-Pereira R. Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity. Int J Mol Sci. 2023;24(15):12032.","journal-title":"Int J Mol Sci"},{"issue":"6294","key":"312_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/347645a0","volume":"347","author":"I Issemann","year":"1990","unstructured":"Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347(6294):645\u201350.","journal-title":"Nature"},{"issue":"8","key":"312_CR26","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","volume":"1771","author":"M Ricote","year":"2007","unstructured":"Ricote M, Glass CK. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta. 2007;1771(8):926\u201335.","journal-title":"Biochim Biophys Acta"},{"key":"312_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102510","volume":"113","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang J, Luo S, Zhan Y, Lu Q. The roles of PPAR\u03b3 and its agonists in autoimmune diseases: a comprehensive review. J Autoimmun. 2020;113:102510.","journal-title":"J Autoimmun"},{"key":"312_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coph.2020.04.001","volume":"53","author":"J Porcuna","year":"2020","unstructured":"Porcuna J, Men\u00e9ndez-Guti\u00e9rrez MP, Ricote M. Molecular control of tissue-resident macrophage identity by nuclear receptors. Curr Opin Pharmacol. 2020;53:27\u201334.","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"312_CR29","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/j.1349-7006.2007.00633.x","volume":"98","author":"YN Kimura","year":"2007","unstructured":"Kimura YN, Watari K, Fotovati A, Hosoi F, Yasumoto K, Izumi H, et al. Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci. 2007;98(12):2009\u201318.","journal-title":"Cancer Sci"},{"issue":"11","key":"312_CR30","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web\u2010based graphical user interface for CHARMM. J Comput Chem. 2008;29(11):1859\u201365.","journal-title":"J Comput Chem"},{"issue":"43","key":"312_CR31","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A. 2001;105(43):9954\u201360.","journal-title":"J Phys Chem A"},{"key":"312_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fimmu.2014.00587","volume":"5","author":"JM Fritz","year":"2014","unstructured":"Fritz JM, Tennis MA, Orlicky DJ, Yin H, Ju C, Redente EF, et al. Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas. Front Immunol. 2014;5:587.","journal-title":"Front Immunol"},{"key":"312_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.addr.2015.11.009","volume":"99","author":"Y Komohara","year":"2016","unstructured":"Komohara Y, Fujiwara Y, Ohnishi K, Takeya M. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv Drug Deliv Rev. 2016;99:180\u20135.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"312_CR34","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1111\/j.1349-7006.2008.00904.x","volume":"99","author":"A Nakajima","year":"2008","unstructured":"Nakajima A, Tomimoto A, Fujita K, Sugiyama M, Takahashi H, Ikeda I, et al. Inhibition of peroxisome proliferator-activated receptor \u03b3 activity suppresses pancreatic cancer cell motility. Cancer Sci. 2008;99(10):1892\u2013900.","journal-title":"Cancer Sci"},{"issue":"20","key":"312_CR35","doi-asserted-by":"publisher","first-page":"6478","DOI":"10.1158\/1078-0432.CCR-08-1128","volume":"14","author":"GD Girnun","year":"2008","unstructured":"Girnun GD, Chen L, Silvaggi J, Drapkin R, Chirieac LR, Padera RF, et al. Regression of drug-resistant lung cancer by the combination of Rosiglitazone and carboplatin. Clin Cancer Res. 2008;14(20):6478\u201386.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"312_CR36","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1189\/jlb.0609385","volume":"86","author":"G Solinas","year":"2009","unstructured":"Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol. 2009;86(5):1065\u201373.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"312_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14\u201320.","journal-title":"Immunity"},{"issue":"5","key":"312_CR38","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1182\/blood-2005-01-0428","volume":"107","author":"SK Biswas","year":"2006","unstructured":"Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-\u03baB and enhanced IRF-3\/STAT1 activation). Blood. 2006;107(5):2112\u201322.","journal-title":"Blood"},{"issue":"5","key":"312_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06746-y","volume":"15","author":"YE Yang","year":"2024","unstructured":"Yang YE, Hu MH, Zeng YC, Tseng YL, Chen YY, Su WC, et al. IL-33\/NF-\u03baB\/ST2L\/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer. Cell Death Dis. 2024;15(5):356.","journal-title":"Cell Death Dis"},{"key":"312_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114527","volume":"161","author":"M Tariq","year":"2023","unstructured":"Tariq M, Hussain N, Rehman K, Akash MSH, Al Haddad AHI, Said ASA, et al. Macrophages M2 polarization is involved in lapatinib-mediated chemopreventive effects in the lung cancer. Biomed Pharmacother. 2023;161:114527.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"312_CR41","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1080\/08820139.2021.1952217","volume":"51","author":"G Liu","year":"2022","unstructured":"Liu G, Luo Y, Hou P. PRPS2 enhances resistance to cisplatin via facilitating exosomes-mediated macrophage M2 polarization in non-small cell lung cancer. Immunol Invest. 2022;51(5):1423\u201336.","journal-title":"Immunol Invest"},{"issue":"1","key":"312_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep14273","volume":"5","author":"A Yuan","year":"2015","unstructured":"Yuan A, Hsiao YJ, Chen HY, Chen HW, Ho CC, Chen YY, et al. Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression. Sci Rep. 2015;5(1):14273.","journal-title":"Sci Rep"},{"key":"312_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03087","volume":"10","author":"L Quero","year":"2020","unstructured":"Quero L, Tiaden AN, Hanser E, Roux J, Laski A, Hall J, et al. Mir-221-3p drives the shift of M2-macrophages to a pro-inflammatory function by suppressing JAK3\/STAT3 activation. Front Immunol. 2020;10:3087.","journal-title":"Front Immunol"},{"issue":"7","key":"312_CR44","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1039\/D1FO04309A","volume":"13","author":"T Li","year":"2022","unstructured":"Li T, Zhang YS, Wan M, Wu W, Yao YF, Li WJ. Ganoderma atrum polysaccharide modulates the M1\/M2 polarization of macrophages linked to the Notch signaling pathway. Food Funct. 2022;13(7):4216\u201328.","journal-title":"Food Funct"},{"key":"312_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01650","volume":"9","author":"A Vidyarthi","year":"2018","unstructured":"Vidyarthi A, Khan N, Agnihotri T, Negi S, Das DK, Aqdas M, et al. TLR-3 stimulation skews M2 macrophages to M1 through IFN-\u03b1\u03b2 signaling and restricts tumor progression. Front Immunol. 2018;9:1650.","journal-title":"Front Immunol"},{"issue":"7","key":"312_CR46","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1021\/acscentsci.9b01235","volume":"6","author":"H Xiao","year":"2020","unstructured":"Xiao H, Guo Y, Li B, Li X, Wang Y, Han S, et al. M2-like tumor-associated macrophage-targeted codelivery of STAT6 inhibitor and IKK\u03b2 siRNA induces M2-to-M1 repolarization for cancer immunotherapy with low immune side effects. ACS Cent Sci. 2020;6(7):1208\u201322.","journal-title":"ACS Cent Sci"},{"issue":"7","key":"312_CR47","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s11010-022-04613-y","volume":"478","author":"X Yang","year":"2023","unstructured":"Yang X, Yang J, Gu X, Tao Y, Ji H, Miao X, et al. (\u2013)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer. Mol Cell Biochem. 2023;478(7):1611\u201320.","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"312_CR48","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1161\/CIRCRESAHA.110.216523","volume":"106","author":"A Chawla","year":"2010","unstructured":"Chawla A. Control of macrophage activation and function by PPARs. Circ Res. 2010;106(10):1559\u201369.","journal-title":"Circ Res"},{"issue":"11","key":"312_CR49","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","volume":"3","author":"F Hossain","year":"2015","unstructured":"Hossain F, Al-Khami AA, Wyczechowska D, Hernandez C, Zheng L, Reiss K, et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer Immunol Res. 2015;3(11):1236\u201347.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"312_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-pathol-011110-130138","volume":"6","author":"JI Odegaard","year":"2011","unstructured":"Odegaard JI, Chawla A. Alternative macrophage activation and metabolism. Annu Rev Pathol Mech Dis. 2011;6(1):275\u201397.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"20","key":"312_CR51","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1097\/CM9.0000000000002426","volume":"135","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang D, Yang L, Zhang Y. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages. Chin Med J. 2022;135(20):2405\u201316.","journal-title":"Chin Med J"},{"issue":"6","key":"312_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-00478-8","volume":"21","author":"J Muri","year":"2021","unstructured":"Muri J, Kopf M. Redox regulation of immunometabolism. Nat Rev Immunol. 2021;21(6):363\u201381.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"312_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00251-y","volume":"9","author":"Y Liu","year":"2021","unstructured":"Liu Y, Xu R, Gu H, Zhang E, Qu J, Cao W, et al. Metabolic reprogramming in macrophage responses. Biomark Res. 2021;9(1):1.","journal-title":"Biomark Res"},{"issue":"2","key":"312_CR54","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4049\/jimmunol.1000866","volume":"185","author":"MVS Rajaram","year":"2010","unstructured":"Rajaram MVS, Brooks MN, Morris JD, Torrelles JB, Azad AK, Schlesinger LS. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor \u03b3 linking mannose receptor recognition to regulation of immune responses. J Immunol. 2010;185(2):929\u201342.","journal-title":"J Immunol"},{"issue":"2","key":"312_CR55","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.lungcan.2011.01.019","volume":"72","author":"AK Reka","year":"2011","unstructured":"Reka AK, Goswami MT, Krishnapuram R, Standiford TJ, Keshamouni VG. Molecular cross-regulation between PPAR-\u03b3 and other signaling pathways: implications for lung cancer therapy. Lung Cancer. 2011;72(2):154\u20139.","journal-title":"Lung Cancer"},{"key":"312_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176304","volume":"964","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xiao B, Liu Y, Wu S, Xiang Q, Xiao Y, et al. Roles of PPAR activation in cancer therapeutic resistance: implications for combination therapy and drug development. Eur J Pharmacol. 2024;964:176304.","journal-title":"Eur J Pharmacol"},{"key":"312_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.682762","volume":"11","author":"R Xu","year":"2021","unstructured":"Xu R, Luo X, Ye X, Li H, Liu H, Du Q, et al. SIRT1\/PGC-1\u03b1\/PPAR-\u03b3 correlate with hypoxia-induced chemoresistance in non-small cell lung cancer. Front Oncol. 2021;11:682762.","journal-title":"Front Oncol"},{"issue":"7","key":"312_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06919-9","volume":"15","author":"G Lin","year":"2024","unstructured":"Lin G, Lin L, Chen X, Chen L, Yang J, Chen Y, et al. PPAR-\u03b3\/NF-kB\/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL-6. Cell Death Dis. 2024;15(7):532.","journal-title":"Cell Death Dis"},{"issue":"4","key":"312_CR59","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12282-022-01356-y","volume":"29","author":"B Ruidas","year":"2022","unstructured":"Ruidas B, Sur TK, Das Mukhopadhyay C, Sinha K, Som Chaudhury S, Sharma P, et al. Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1. Breast Cancer. 2022;29(4):748\u201360.","journal-title":"Breast Cancer"},{"issue":"6","key":"312_CR60","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1111\/cas.14011","volume":"110","author":"Q Du","year":"2019","unstructured":"Du Q, Tan Z, Shi F, Tang M, Xie L, Zhao L. PGC1\u03b1\/CEBPB\/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation. Cancer Sci. 2019;110(6):2050\u201362.","journal-title":"Cancer Sci"},{"issue":"1","key":"312_CR61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang T, Fahrmann JF, Lee H, Li Y, Tripathi SC, Yue C, et al. JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 2018;27(1):136\u2013e505.","journal-title":"Cell Metab"},{"issue":"6","key":"312_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-024-00355-w","volume":"24","author":"R Yan","year":"2024","unstructured":"Yan R, Zheng C, Qian S, Li K, Kong X, Liao S. The ZNF263\/CPT1B axis regulates fatty acid \u03b2-oxidation to affect cisplatin resistance in lung adenocarcinoma. Pharmacogenomics J. 2024;24(6):33.","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"312_CR63","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.surg.2023.12.019","volume":"175","author":"A Tuerhong","year":"2024","unstructured":"Tuerhong A, Xu J, Wang W, Shi S, Meng Q, Hua J, et al. CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1\/NRF2 axis in pancreatic cancer. Surgery. 2024;175(5):1264\u201375.","journal-title":"Surgery"},{"issue":"12","key":"312_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121605","volume":"12","author":"WW Feng","year":"2023","unstructured":"Feng WW, Zuppe HT, Kurokawa M. The role of CD36 in cancer progression and its value as a therapeutic target. Cells. 2023;12(12):1605.","journal-title":"Cells"},{"issue":"1","key":"312_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye H, Adane B, Khan N, Sullivan T, Minhajuddin M, Gasparetto M, et al. Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell. 2016;19(1):23\u201337.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"312_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1773204","volume":"9","author":"LA Aguirre","year":"2020","unstructured":"Aguirre LA, Montalb\u00e1n-Hern\u00e1ndez K, Avenda\u00f1o-Ortiz J, Mar\u00edn E, Lozano R, Toledano V, et al. Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells. Oncoimmunology. 2020;9(1):1773204.","journal-title":"Oncoimmunology"},{"key":"312_CR67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2018.09.006","volume":"438","author":"P Yang","year":"2018","unstructured":"Yang P, Su C, Luo X, Zeng H, Zhao L, Wei L, et al. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src\/ERK pathway. Cancer Lett. 2018;438:76\u201385.","journal-title":"Cancer Lett"},{"issue":"3","key":"312_CR68","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang H, Franco F, Tsui YC, Xie X, Trefny MP, Zappasodi R, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21(3):298\u2013308.","journal-title":"Nat Immunol"},{"issue":"7","key":"312_CR69","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.cmet.2024.04.018","volume":"36","author":"F Peng","year":"2024","unstructured":"Peng F, Lu J, Su K, Liu X, Luo H, He B, et al. Oncogenic fatty acid oxidation senses circadian disruption in sleep-deficiency-enhanced tumorigenesis. Cell Metab. 2024;36(7):1598\u2013e61811.","journal-title":"Cell Metab"},{"issue":"23","key":"312_CR70","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1158\/1078-0432.CCR-07-1186","volume":"13","author":"H Orita","year":"2007","unstructured":"Orita H, Coulter J, Lemmon C, Tully E, Vadlamudi A, Medghalchi SM, et al. Selective inhibition of fatty acid synthase for lung cancer treatment. Clin Cancer Res. 2007;13(23):7139\u201345.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"312_CR71","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.celrep.2016.07.009","volume":"16","author":"MS Padanad","year":"2016","unstructured":"Padanad MS, Konstantinidou G, Venkateswaran N, Melegari M, Rindhe S, Mitsche M, et al. Fatty acid oxidation mediated by Acyl-CoA synthetase long chain 3 is required for mutant KRAS lung tumorigenesis. Cell Rep. 2016;16(6):1614\u201328.","journal-title":"Cell Rep"},{"issue":"20","key":"312_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011185","volume":"25","author":"MK Singh","year":"2024","unstructured":"Singh MK, Han S, Kim S, Kang I. Targeting lipid metabolism in cancer stem cells for anticancer treatment. Int J Mol Sci. 2024;25(20):11185.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"312_CR73","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13(4):227\u201332.","journal-title":"Nat Rev Cancer"}],"container-title":["Biological Procedures Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-025-00312-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-025-00312-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-025-00312-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:02:59Z","timestamp":1768388579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12575-025-00312-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1186\/s12575-025-00312-2","relation":{},"ISSN":["1480-9222"],"issn-type":[{"value":"1480-9222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval to report this case was obtained from the ethics committee of experimental animal medicine of Shanghai Hospital of Traditional Chinese Medicine (2024141, approved on 20 July 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1"}}